| Abbvie Inc. | 44,415 | US$11.2M | 8.2% |
| Amgen Inc. | 19,065 | US$6.9M | 5.0% |
| Gilead Sciences, Inc. | 48,654 | US$6.15M | 4.5% |
| Vertex Pharmaceuticals Incorporated | 11,897 | US$5.91M | 4.3% |
| Regeneron Pharmaceuticals, Inc. | 6,432 | US$4.01M | 2.9% |
| Revolution Medicines, Inc. | 18,109 | US$3.39M | 2.5% |
| Alnylam Pharmaceuticals, Inc. | 10,721 | US$3.23M | 2.4% |
| Beone Medicines Ltd. Class A | 10,427 | US$2.97M | 2.2% |
| Moderna, Inc. | 41,976 | US$2.94M | 2.1% |
| Biogen Inc. | 13,465 | US$2.91M | 2.1% |
| Natera, Inc. | 10,672 | US$2.9M | 2.1% |
| Royalty Pharma Plc | 49,095 | US$2.75M | 2.0% |
| Illumina, Inc. | 15,058 | US$2.65M | 1.9% |
| Insmed Incorporated | 22,998 | US$2.45M | 1.8% |
| United Therapeutics Corporation | 4,350 | US$2.36M | 1.7% |
| Guardant Health, Inc. | 15,671 | US$2.35M | 1.7% |
| Roivant Sciences Ltd. | 64,115 | US$2.27M | 1.7% |
| Incyte Corporation | 19,518 | US$2.21M | 1.6% |
| Viatris Inc. | 134K | US$2.12M | 1.6% |
| Neurocrine Biosciences, Inc. | 12,363 | US$2.08M | 1.5% |
| Argenx Se | 2,181 | US$2.02M | 1.5% |
| Jazz Pharmaceuticals Plc | 8,037 | US$1.94M | 1.4% |
| Bridgebio Pharma, Inc. | 25,399 | US$1.89M | 1.4% |
| Ionis Pharmaceuticals, Inc. | 23,328 | US$1.85M | 1.4% |
| Cytokinetics, Incorporated | 21,687 | US$1.85M | 1.4% |
| Exelixis, Inc. | 33,461 | US$1.82M | 1.3% |
| Alkermes Plc | 34,306 | US$1.8M | 1.3% |
| Arrowhead Pharmaceuticals, Inc. | 20,951 | US$1.71M | 1.2% |
| Biomarin Pharmaceutical Inc. | 29,626 | US$1.7M | 1.2% |
| Astrazeneca Plc | 8,846 | US$1.68M | 1.2% |
| Halozyme Therapeutics, Inc. | 20,474 | US$1.6M | 1.2% |
| Crispr Therapeutics Ag | 29,038 | US$1.58M | 1.2% |
| Vaxcyte, Inc. | 27,188 | US$1.58M | 1.2% |
| Tg Therapeutics, Inc. | 27,004 | US$1.48M | 1.1% |
| Medpace Holdings, Inc. | 2,659 | US$1.41M | 1.0% |
| Apogee Therapeutics, Inc. | 10,512 | US$1.4M | 1.0% |
| Cogent Biosciences, Inc. | 35,458 | US$1.37M | 1.0% |
| Twist Bioscience Corporation | 13,098 | US$1.35M | 0.98% |
| Ptc Therapeutics, Inc. | 16,516 | US$1.35M | 0.98% |
| Scholar Rock Holding Corporation | 24,468 | US$1.35M | 0.98% |
| Nuvalent, Inc. | 10,892 | US$1.35M | 0.98% |
| Axsome Therapeutics, Inc. | 5,367 | US$1.31M | 0.96% |
| Cg Oncology, Inc. | 18,440 | US$1.31M | 0.96% |
| Krystal Biotech, Inc. | 3,406 | US$1.27M | 0.93% |
| Viking Therapeutics, Inc. | 31,452 | US$1.23M | 0.90% |
| Travere Therapeutics, Inc. | 21,589 | US$1.23M | 0.90% |
| Protagonist Therapeutics, Inc. | 9,900 | US$1.21M | 0.89% |
| Ascendis Pharma A/s | 4,546 | US$1.21M | 0.89% |
| Veracyte, Inc. | 20,449 | US$1.2M | 0.88% |
| Liquidia Corporation | 14,813 | US$1.18M | 0.86% |
| Kymera Therapeutics, Inc. | 9,937 | US$1.14M | 0.83% |
| Madrigal Pharmaceuticals, Inc. | 2,022 | US$1.09M | 0.79% |
| Ultragenyx Pharmaceutical Inc. | 31,574 | US$1.05M | 0.77% |
| Beam Therapeutics Inc. | 29,626 | US$1.02M | 0.74% |
| Immunitybio, Inc. | 116K | US$1.01M | 0.74% |
| Mirum Pharmaceuticals, Inc. | 8,626 | US$1.01M | 0.74% |
| Praxis Precision Medicines, Inc. | 2,953 | US$989K | 0.72% |
| Rhythm Pharmaceuticals, Inc. | 8,809 | US$978K | 0.71% |
| Acadia Pharmaceuticals Inc. | 38,546 | US$975K | 0.71% |
| Intellia Therapeutics, Inc. | 52,464 | US$888K | 0.65% |
| Arcutis Biotherapeutics, Inc. | 32,799 | US$860K | 0.63% |
| Recursion Pharmaceuticals, Inc. | 204K | US$749K | 0.55% |
| Sarepta Therapeutics, Inc. | 41,327 | US$743K | 0.54% |
| Summit Therapeutics Inc. | 49,916 | US$727K | 0.53% |
| Adma Biologics Inc | 82,224 | US$688K | 0.50% |
| Celcuity Inc. | 5,918 | US$619K | 0.45% |
| Grail, Inc. | 7,633 | US$521K | 0.38% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Apellis Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |